Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Infection with group A Streptococcus]

C O Solberg1, J Chelsom

  • 1Seksjon for infektionssykdommer, Medisinsk avd, Haukeland Sykehus, Bergen.

Nordisk Medicin
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibiotic susceptibility of blood culture isolates of Enterobacteriaceae. A Norwegian multicenter study.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2002
Same author

[Treatment of acute bacterial meningitis].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2002
Same author

[Streptococcus group A infections of skin, soft tissue and blood].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2002
Same author

[Microorganisms strike back--infectious diseases during the last 50 years].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2002
Same author

Spread of Staphylococcus aureus in hospitals: causes and prevention.

Scandinavian journal of infectious diseases·2001
Same author

Training for the infectious diseases speciality in Norway.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2001
Same journal

[Nordisk Medicine 1929-1998. Thanks and farewell!].

Nordisk medicin·1999
Same journal

[Scientific fraud and misconduct--need for comprehensive terminology].

Nordisk medicin·1999
Same journal

[Labor-market for Scandinavian physicians in the year 2000--dearth or surplus?].

Nordisk medicin·1999
Same journal

[Internet in consultation--headed for trouble?].

Nordisk medicin·1999
Same journal

[Interpretation of questionnaires. An translation method problem].

Nordisk medicin·1999
Same journal

[Assessment of patients' health status--review of the literature and assessment methods].

Nordisk medicin·1999
See all related articles

Severe group A streptococcus (GAS) infections are rising in industrialized nations, often in healthy individuals. Increased virulence of GAS strains, particularly M types 1 and 3, contributes to high mortality rates.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Epidemiology

Context:

  • Significant increase in severe group A streptococcus (GAS) infections observed in industrialized countries over the past 8-10 years.
  • Predominant occurrence in otherwise healthy adolescents and adults.
  • GAS strains, predominantly M types 1 and 3, exhibit increased virulence due to pyrogenic exotoxin production.

Purpose:

  • To report on the prevalence of severe GAS infections.
  • To elucidate the pathogenesis of these severe infections.
  • To describe the clinical features and treatment strategies for severe GAS infections.

Summary:

  • Severe GAS infections, including bacteremia, erysipelas, necrotizing fasciitis, and puerperal fever, are increasingly prevalent.
  • Commonly present with shock, acute respiratory distress syndrome, and multiorgan failure, leading to up to 30% attributable mortality.

Related Experiment Videos

  • M types 1 and 3 GAS strains producing pyrogenic exotoxins are frequently implicated, suggesting enhanced virulence.

    • Impact:

    • Highlights the growing public health concern of invasive GAS infections.
    • Informs clinicians about the changing epidemiology and clinical presentation of severe GAS disease.
    • Provides essential information for developing effective treatment and prevention strategies against highly virulent GAS strains.